Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Effects of Alzheimer's Disease and Lewy Body Disease on Subcortical Atrophy.

Yoo HS, Lee EC, Chung SJ, Lee YH, Gu Lee S, Yun M, Lee PH, Sohn YH, Sung JK, Ye BS.

Eur J Neurol. 2019 Sep 5. doi: 10.1111/ene.14080. [Epub ahead of print]

PMID:
31487756
2.

Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease.

Lee YH, Cha J, Chung SJ, Yoo HS, Sohn YH, Ye BS, Lee PH.

Sci Rep. 2019 Jul 19;9(1):10531. doi: 10.1038/s41598-019-47026-6.

3.

White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.

Chung SJ, Lee YH, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2019 Jul 15. pii: S1353-8020(19)30309-8. doi: 10.1016/j.parkreldis.2019.07.019. [Epub ahead of print]

PMID:
31324555
4.

Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.

Chung SJ, Yoo HS, Lee YH, Lee HS, Ye BS, Sohn YH, Kwon H, Lee PH.

Hum Brain Mapp. 2019 Sep;40(13):3784-3794. doi: 10.1002/hbm.24631. Epub 2019 May 14.

PMID:
31090134
5.

Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson's disease.

Yoo HS, Chung SJ, Lee YH, Ye BS, Sohn YH, Lee PH.

J Neurol. 2019 Jul;266(7):1601-1610. doi: 10.1007/s00415-019-09297-x. Epub 2019 Apr 22.

PMID:
31011798
6.

Distinct FP-CIT PET patterns of Alzheimer's disease with parkinsonism and dementia with Lewy bodies.

Chung SJ, Lee YH, Yoo HS, Sohn YH, Ye BS, Cha J, Lee PH.

Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1652-1660. doi: 10.1007/s00259-019-04315-6. Epub 2019 Apr 12.

PMID:
30980099
7.

Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.

Chung SJ, Park YH, Yoo HS, Lee YH, Ye BS, Sohn YH, Lee JM, Lee PH.

Neurobiol Aging. 2019 Jun;78:168-177. doi: 10.1016/j.neurobiolaging.2019.02.023. Epub 2019 Mar 11.

PMID:
30947112
8.

Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction.

Kang SW, Jeon S, Yoo HS, Chung SJ, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS.

Neurology. 2019 Apr 23;92(17):e2015-e2026. doi: 10.1212/WNL.0000000000007373. Epub 2019 Apr 3.

PMID:
30944239
9.

Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD.

Yoo HS, Chung SJ, Lee YH, Lee HS, Ye BS, Sohn YH, Lee PH.

Neurology. 2019 Mar 26;92(13):e1468-e1478. doi: 10.1212/WNL.0000000000007189. Epub 2019 Feb 22.

PMID:
30796137
10.

Gastrectomy and nigrostriatal dopaminergic depletion in de novo Parkinson's disease.

Chung SJ, Jeon S, Yoo HS, Yoon JH, Lee JE, Kim JS, Kim SJ, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Mov Disord. 2019 Feb;34(2):299-301. doi: 10.1002/mds.27580. Epub 2018 Dec 10. No abstract available.

PMID:
30537370
11.

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.

Kim SE, Woo S, Kim SW, Chin J, Kim HJ, Lee BI, Park J, Park KW, Kang DY, Noh Y, Ye BS, Yoo HS, Lee JS, Kim Y, Kim SJ, Cho SH, Na DL, Lockhart SN, Jang H, Seo SW.

J Alzheimers Dis. 2018;66(2):681-691. doi: 10.3233/JAD-180048.

PMID:
30320571
12.

Amyloid-β-related and unrelated cortical thinning in dementia with Lewy bodies.

Lee YG, Jeon S, Yoo HS, Chung SJ, Lee SK, Lee PH, Sohn YH, Yun M, Evans AC, Ye BS.

Neurobiol Aging. 2018 Dec;72:32-39. doi: 10.1016/j.neurobiolaging.2018.08.007. Epub 2018 Aug 11.

PMID:
30205358
13.

Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.

Yoo HS, Jeon S, Chung SJ, Yun M, Lee PH, Sohn YH, Evans AC, Ye BS.

Alzheimers Dement. 2018 Oct;14(10):1243-1252. doi: 10.1016/j.jalz.2018.05.010. Epub 2018 Jun 21.

PMID:
29936148
14.

The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage.

Yoo HS, Chung SJ, Kim SJ, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1585-1595. doi: 10.1007/s00259-018-4019-y. Epub 2018 May 4.

PMID:
29728749
15.

Longitudinal outcomes of amyloid positive versus negative amnestic mild cognitive impairments: a three-year longitudinal study.

Ye BS, Kim HJ, Kim YJ, Jung NY, Lee JS, Lee J, Jang YK, Yang JJ, Lee JM, Vogel JW, Na DL, Seo SW.

Sci Rep. 2018 Apr 3;8(1):5557. doi: 10.1038/s41598-018-23676-w.

16.

Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

Chung SJ, Yoo HS, Oh JS, Kim JS, Ye BS, Sohn YH, Lee PH.

Parkinsonism Relat Disord. 2018 Jun;51:43-48. doi: 10.1016/j.parkreldis.2018.02.048. Epub 2018 Mar 2.

PMID:
29526657
17.

Prediction Model of Conversion to Dementia Risk in Subjects with Amnestic Mild Cognitive Impairment: A Longitudinal, Multi-Center Clinic-Based Study.

Jang H, Ye BS, Woo S, Kim SW, Chin J, Choi SH, Jeong JH, Yoon SJ, Yoon B, Park KW, Hong YJ, Kim HJ, Lockhart SN, Na DL, Seo SW.

J Alzheimers Dis. 2018;61(2):825. doi: 10.3233/JAD-179010. No abstract available.

PMID:
29278893
18.

Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.

Yoo HS, Chung SJ, Chung SJ, Moon H, Oh JS, Kim JS, Hong JY, Ye BS, Sohn YH, Lee PH.

Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):423-431. doi: 10.1007/s00259-017-3844-8. Epub 2017 Oct 26.

PMID:
29075830
19.

Prediction Model of Conversion to Dementia Risk in Subjects with Amnestic Mild Cognitive Impairment: A Longitudinal, Multi-Center Clinic-Based Study.

Jang H, Ye BS, Woo S, Kim SW, Chin J, Choi SH, Jeong JH, Yoon SJ, Yoon B, Park KW, Hong YJ, Kim HJ, Lockhart SN, Na DL, Seo SW.

J Alzheimers Dis. 2017;60(4):1579-1587. doi: 10.3233/JAD-170507. Erratum in: J Alzheimers Dis. 2018;61(2):825.

PMID:
28968237
20.

Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson's disease.

Ye BS, Jeon S, Yoon S, Kang SW, Baik K, Lee Y, Chung SJ, Oh JS, Moon H, Kim JS, Lee PH, Sohn YH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):197-204. doi: 10.1136/jnnp-2017-316075. Epub 2017 Sep 26.

PMID:
28951497
21.

Dementia-Predicting Cognitive Risk Score and Its Correlation with Cortical Thickness in Parkinson Disease.

Ye BS, Jeon S, Ham JH, Lee JJ, Lee JM, Lee HS, Lee PH, Sohn YH.

Dement Geriatr Cogn Disord. 2017;44(3-4):203-212. doi: 10.1159/000479057. Epub 2017 Sep 21.

PMID:
28930751
22.

Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction.

Chung SJ, Yoo HS, Moon H, Oh JS, Kim JS, Park YH, Hong JY, Ye BS, Sohn YH, Lee PH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):169-174. doi: 10.1136/jnnp-2017-315873. Epub 2017 Sep 14.

PMID:
28912301
23.

Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models.

Oh SH, Lee SC, Kim DY, Kim HN, Shin JY, Ye BS, Lee PH.

Stem Cells. 2017 Aug;35(8):1934-1947. doi: 10.1002/stem.2650. Epub 2017 Jun 27.

24.

The association of environmental toxicants and autism spectrum disorders in children.

Ye BS, Leung AOW, Wong MH.

Environ Pollut. 2017 Aug;227:234-242. doi: 10.1016/j.envpol.2017.04.039. Epub 2017 May 2. Review.

PMID:
28475976
25.

Sleep Disturbance May Alter White Matter and Resting State Functional Connectivities in Parkinson's Disease.

Chung SJ, Choi YH, Kwon H, Park YH, Yun HJ, Yoo HS, Moon SH, Ye BS, Sohn YH, Lee JM, Lee PH.

Sleep. 2017 Mar 1;40(3). doi: 10.1093/sleep/zsx009.

PMID:
28364425
26.

Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease in South Korea.

Park SA, Chae WS, Kim HJ, Shin HS, Kim S, Im JY, Ahn SI, Min KD, Yim SJ, Ye BS, Seo SW, Jeong JH, Park KW, Choi SH, Na DL.

Alzheimer Dis Assoc Disord. 2017 Jan-Mar;31(1):13-18. doi: 10.1097/WAD.0000000000000184.

27.

Premorbid exercise engagement and motor reserve in Parkinson's disease.

Sunwoo MK, Lee JE, Hong JY, Ye BS, Lee HS, Oh JS, Kim JS, Lee PH, Sohn YH.

Parkinsonism Relat Disord. 2017 Jan;34:49-53. doi: 10.1016/j.parkreldis.2016.10.023. Epub 2016 Nov 1.

PMID:
27852513
28.

Influence of personality on depression, burden, and health-related quality of life in family caregivers of persons with dementia.

Kim SK, Park M, Lee Y, Choi SH, Moon SY, Seo SW, Park KW, Ku BD, Han HJ, Park KH, Han SH, Kim EJ, Lee JH, Park SA, Shim YS, Kim JH, Hong CH, Na DL, Ye BS, Kim HJ, Moon Y.

Int Psychogeriatr. 2017 Feb;29(2):227-237. doi: 10.1017/S1041610216001770. Epub 2016 Oct 26.

PMID:
27780493
29.

Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson's Disease Dementia.

Kim Y, Lee D, Cho KH, Lee JJ, Ham JH, Ye BS, Lee SK, Lee JM, Sohn YH, Lee PH.

J Alzheimers Dis. 2017;55(2):485-495.

PMID:
27662310
30.

The moderating effect of religiosity on caregiving burden and depressive symptoms in caregivers of patients with dementia.

Yoon KH, Moon YS, Lee Y, Choi SH, Moon SY, Seo SW, Park KW, Ku BD, Han HJ, Park KH, Han SH, Kim EJ, Lee JH, Park SA, Shim YS, Kim JH, Hong CH, Na DL, Ye BS, Kim HJ, Moon Y, Lee SS, Kim DH; CARE (Caregivers of Alzheimer's Disease Research) Investigators.

Aging Ment Health. 2018 Jan;22(1):141-147. doi: 10.1080/13607863.2016.1232366. Epub 2016 Sep 23.

PMID:
27661263
31.

Higher Physical Activity Is Associated with Increased Attentional Network Connectivity in the Healthy Elderly.

Kim GH, Im K, Kwon H, Seo SW, Ye BS, Cho H, Noh Y, Lee JM, Kim ST, Park SE, Kim H, Hwang JW, Kang SJ, Jeong JH, Na DL.

Front Aging Neurosci. 2016 Aug 22;8:198. doi: 10.3389/fnagi.2016.00198. eCollection 2016.

32.

The Role of Cerebrovascular Disease in Amyloid Deposition.

Noh Y, Seo SW, Jeon S, Lee JM, Kim JS, Lee JH, Kim JH, Kim GH, Ye BS, Cho H, Kim HJ, Yoon CW, Choe YS, Lee KH, Weiner MW, Na DL.

J Alzheimers Dis. 2016 Oct 4;54(3):1015-1026.

PMID:
27567803
33.

Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.

Chung SJ, Lee JJ, Ham JH, Ye BS, Lee PH, Sohn YH.

PLoS One. 2016 Aug 16;11(8):e0161316. doi: 10.1371/journal.pone.0161316. eCollection 2016.

34.

Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.

Ye BS, Lee Y, Kwak K, Park YH, Ham JH, Lee JJ, Shin NY, Lee JM, Sohn YH, Lee PH.

J Alzheimers Dis. 2016 Apr 21;52(4):1237-43. doi: 10.3233/JAD-160062.

PMID:
27104902
35.

Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?

Ye BS, Lee WW, Ham JH, Lee JJ, Lee PH, Sohn YH; Alzheimer's Disease Neuroimaging Initiative.

Eur J Neurol. 2016 May;23(5):948-57. doi: 10.1111/ene.12969. Epub 2016 Feb 24.

PMID:
26917248
36.

The Computerized Table Setting Test for Detecting Unilateral Neglect.

Chung SJ, Park E, Ye BS, Lee HS, Chang HJ, Song D, Kim YD, Heo JH, Nam HS.

PLoS One. 2016 Jan 15;11(1):e0147030. doi: 10.1371/journal.pone.0147030. eCollection 2016.

37.

Unstable Body Mass Index and Progression to Probable Alzheimer's Disease Dementia in Patients with Amnestic Mild Cognitive Impairment.

Ye BS, Jang EY, Kim SY, Kim EJ, Park SA, Lee Y, Hong CH, Choi SH, Yoon B, Yoon SJ, Na HR, Lee JH, Jeong JH, Kim HJ, Na DL, Seo SW.

J Alzheimers Dis. 2016;49(2):483-91. doi: 10.3233/JAD-150556.

PMID:
26484923
38.

Effects of amyloid and vascular markers on cognitive decline in subcortical vascular dementia.

Ye BS, Seo SW, Kim JH, Kim GH, Cho H, Noh Y, Kim HJ, Yoon CW, Woo SY, Kim SH, Park HK, Kim ST, Choe YS, Lee KH, Kim JS, Oh SJ, Kim C, Weiner M, Lee JH, Na DL.

Neurology. 2015 Nov 10;85(19):1687-93. doi: 10.1212/WNL.0000000000002097. Epub 2015 Oct 14.

39.

Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.

Kim HJ, Park KW, Kim TE, Im JY, Shin HS, Kim S, Lee DH, Ye BS, Kim JH, Kim EJ, Park KH, Han HJ, Jeong JH, Choi SH, Park SA.

J Alzheimers Dis. 2015;48(4):1043-50. doi: 10.3233/JAD-143018.

PMID:
26444752
40.

Impact of smoking on neurodegeneration and cerebrovascular disease markers in cognitively normal men.

Cho H, Kim C, Kim HJ, Ye BS, Kim YJ, Jung NY, Son TO, Cho EB, Jang H, Lee J, Kang M, Shin HY, Jeon S, Lee JM, Kim ST, Choi YC, Na DL, Seo SW.

Eur J Neurol. 2016 Jan;23(1):110-9. doi: 10.1111/ene.12816. Epub 2015 Aug 11.

PMID:
26264353
41.

Effects of education on aging-related cortical thinning among cognitively normal individuals.

Kim JP, Seo SW, Shin HY, Ye BS, Yang JJ, Kim C, Kang M, Jeon S, Kim HJ, Cho H, Kim JH, Lee JM, Kim ST, Na DL, Guallar E.

Neurology. 2015 Sep 1;85(9):806-12. doi: 10.1212/WNL.0000000000001884. Epub 2015 Jul 31.

PMID:
26231257
42.

Clinical effect of white matter network disruption related to amyloid and small vessel disease.

Kim HJ, Im K, Kwon H, Lee JM, Kim C, Kim YJ, Jung NY, Cho H, Ye BS, Noh Y, Kim GH, Ko ED, Kim JS, Choe YS, Lee KH, Kim ST, Lee JH, Ewers M, Weiner MW, Na DL, Seo SW.

Neurology. 2015 Jul 7;85(1):63-70. doi: 10.1212/WNL.0000000000001705. Epub 2015 Jun 10.

43.

Decreased hemoglobin levels, cerebral small-vessel disease, and cortical atrophy: among cognitively normal elderly women and men.

Park SE, Kim H, Lee J, Lee NK, Hwang JW, Yang JJ, Ye BS, Cho H, Kim HJ, Kim YJ, Jung NY, Son TO, Cho EB, Jang H, Jang EY, Hong CH, Lee JM, Kang M, Shin HY, Na DL, Seo SW.

Int Psychogeriatr. 2016 Jan;28(1):147-56. doi: 10.1017/S1041610215000733. Epub 2015 May 20.

PMID:
25990664
44.

Structural brain changes after traditional and robot-assisted multi-domain cognitive training in community-dwelling healthy elderly.

Kim GH, Jeon S, Im K, Kwon H, Lee BH, Kim GY, Jeong H, Han NE, Seo SW, Cho H, Noh Y, Park SE, Kim H, Hwang JW, Yoon CW, Kim HJ, Ye BS, Chin JH, Kim JH, Suh MK, Lee JM, Kim ST, Choi MT, Kim MS, Heilman KM, Jeong JH, Na DL.

PLoS One. 2015 Apr 21;10(4):e0123251. doi: 10.1371/journal.pone.0123251. eCollection 2015.

45.

Contraversive ocular tilt reaction after the lateral medullary infarction.

Cho KH, Kim YD, Kim J, Ye BS, Heo JH, Nam HS.

Neurologist. 2015 Feb;19(3):79-81. doi: 10.1097/NRL.0000000000000015.

PMID:
25692514
46.

Association of Body Fat Percentage and Waist-hip Ratio With Brain Cortical Thickness: A Study Among 1777 Cognitively Normal Subjects.

Kim HJ, Kim C, Jeon S, Kang M, Kim YJ, Lee JM, Shin HY, Cho H, Ye BS, Kim JH, Jang EY, Cho J, Na DL, Rexrode KM, Seo SW.

Alzheimer Dis Assoc Disord. 2015 Oct-Dec;29(4):279-86. doi: 10.1097/WAD.0000000000000079.

PMID:
25626634
47.

Clinical and Neuropsychological Comparisons of Early-Onset Versus Late-Onset Frontotemporal Dementia: A CREDOS-FTD Study.

Ye BS, Choi SH, Han SH, Kim S, Yang DW, Park KH, Han HJ, Youn YC, Choi BO, Kim SH, Woo SY, Na DL, Kim EJ.

J Alzheimers Dis. 2015;45(2):599-608.

PMID:
25589724
48.

Postmorbid learning of saxophone playing in a patient with frontotemporal dementia.

Cho H, Chin J, Suh MK, Kim HJ, Kim YJ, Ye BS, Lee NK, Kim EJ, Seo SW, Na DL.

Neurocase. 2015;21(6):767-72. doi: 10.1080/13554794.2014.992915. Epub 2015 Jan 14.

PMID:
25587661
49.

Hippocampal volume and shape in pure subcortical vascular dementia.

Kim GH, Lee JH, Seo SW, Kim JH, Seong JK, Ye BS, Cho H, Noh Y, Kim HJ, Yoon CW, Oh SJ, Kim JS, Choe YS, Lee KH, Kim ST, Hwang JW, Jeong JH, Na DL.

Neurobiol Aging. 2015 Jan;36(1):485-91. doi: 10.1016/j.neurobiolaging.2014.08.009. Epub 2014 Sep 28.

PMID:
25444608
50.

Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.

Kim YJ, Cho H, Kim YJ, Ki CS, Chung SJ, Ye BS, Kim HJ, Kim JH, Kim ST, Lee KH, Jeon S, Lee JM, Chin J, Kim JH, Na DL, Seong JK, Seo SW.

J Alzheimers Dis. 2015;44(4):1075-85. doi: 10.3233/JAD-141773.

PMID:
25391384

Supplemental Content

Support Center